Sapient Capital’s ResMed RMD Stock Holding History

Sapient Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,097	Closed	-$246K	–	466
2026 Q1	$246K	Buy	+1,097	New	+$273K	﹤0.01%	399

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

CISOA

Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Sapient Capital's RMD Position: Q2 2026 in Review

Sapient Capital sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,097 shares — an estimated $246K sold.

Sapient Capital first reported a position in RMD in Q1 2026 and held it in 1 quarter. The position peaked at $246K in Q1 2026. 148 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Sapient Capital reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Sapient Capital sold 1,097 ResMed shares in Q2 2026, an estimated $246K.
Sapient Capital first reported a position in ResMed in Q1 2026 and held it in 1 quarter.
Sapient Capital's ResMed position peaked at $246K in Q1 2026.
148 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.